Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Platelet aggregation is crucial for hemostasis and thrombosis.
• Glycoprotein VI (GPVI) is a key receptor in platelet activation.
• Convulxin, a snake venom toxin, selectively activates GPVI.

Purpose of the Study:

• To investigate the roles of secretion and intracellular signaling in platelet aggregation induced by convulxin and collagen.
• To compare the signaling pathways activated by convulxin versus collagen.

Main Methods:

• Utilized convulxin and collagen to induce platelet aggregation in murine platelets.
• Employed inhibitors of ADP receptors (P2Y1, P2Y12), thromboxanes, and protein kinase C.
• Used dense granule-deficient platelets (pearl mice) to assess agonist release.
• Chelated intracellular calcium (Ca2+) using BAPTA-AM.

Main Results:

• Convulxin-induced aggregation synergized with ADP via P2Y12 but not P2Y1 or thromboxanes.
• Inhibitors of secondary agonists marginally affected convulxin-induced aggregation but severely impacted collagen response.
• Protein kinase C inhibition reduced convulxin-induced aggregation in pearl platelets.
• Intracellular Ca2+ chelation abolished convulxin-induced aggregation.
• ADP potentiated convulxin-induced phospholipase C activation via P2Y12.

Conclusions:

• Calcium (Ca2+) and protein kinase C are essential for full convulxin-induced platelet aggregation.
• Release of secondary agonists (ADP, thromboxane A2) is not required for convulxin-induced aggregation.
• Collagen-induced aggregation is significantly more dependent on secondary agonist secretion than convulxin-induced aggregation.